DMRT2 | Doublesex and mab-3 related transcription factor 2 | Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
DMRT3 | Doublesex and mab-3 related transcription factor 3 | Transcription factors
| | | | | Tissue enhanced |
DMRTA1 | DMRT-like family A1 | Transcription factors
| | | | | Mixed |
DMRTA2 | DMRT-like family A2 | Predicted secreted proteins Transcription factors
| | | | | Not detected |
DMRTB1 | DMRT-like family B with proline-rich C-terminal, 1 | Transcription factors
| | | | | Tissue enriched |
DMRTC1 | DMRT-like family C1 | Transcription factors
| | | | | Tissue enhanced |
DMRTC1B | DMRT-like family C1B | Transcription factors
| | | | | Tissue enhanced |
DMRTC2 | DMRT-like family C2 | Transcription factors
| | | | | Tissue enriched |
DMTF1 | Cyclin D binding myb-like transcription factor 1 | Transcription factors
| | | | | Expressed in all |
DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 | Predicted membrane proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
DNAJC2 | DnaJ (Hsp40) homolog, subfamily C, member 2 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Tissue enhanced |
DNMT3L | DNA (cytosine-5-)-methyltransferase 3-like | Transcription factors
| | | | | Group enriched |
DPRX | Divergent-paired related homeobox | Transcription factors
| | | | | Tissue enhanced |
DRGX | Dorsal root ganglia homeobox | Transcription factors
| | | | | Tissue enriched |
DUXA | Double homeobox A | Transcription factors
| | | | | Not detected |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
E2F2 | E2F transcription factor 2 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
E2F3 | E2F transcription factor 3 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
E2F4 | E2F transcription factor 4, p107/p130-binding | Transcription factors
| | | | | Expressed in all |
E2F5 | E2F transcription factor 5, p130-binding | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transcription factors
| | | | | Mixed |
E4F1 | E4F transcription factor 1 | Transcription factors
| | | | | Expressed in all |
EBF2 | Early B-cell factor 2 | Transcription factors
| | | | | Tissue enhanced |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
EGR3 | Early growth response 3 | Transcription factors
| | | | | Mixed |
EGR4 | Early growth response 4 | Transcription factors
| | | | | Group enriched |
EHF | Ets homologous factor | Predicted secreted proteins Transcription factors
| | | | | Mixed |
ELF1 | E74-like factor 1 (ets domain transcription factor) | Transcription factors
| | | | | Expressed in all |
ELF2 | E74-like factor 2 (ets domain transcription factor) | Transcription factors
| | | | | Expressed in all |
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | Cancer-related genes Transcription factors
| | | | | Mixed |
ELF4 | E74-like factor 4 (ets domain transcription factor) | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
ELK1 | ELK1, member of ETS oncogene family | RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
ELK4 | ELK4, ETS-domain protein (SRF accessory protein 1) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ELMSAN1 | ELM2 and Myb/SANT-like domain containing 1 | Transcription factors
| | | | | Expressed in all |
EMX1 | Empty spiracles homeobox 1 | Transcription factors
| | | | | Tissue enriched |
EMX2 | Empty spiracles homeobox 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
EN1 | Engrailed homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
EN2 | Engrailed homeobox 2 | Disease related genes Transcription factors
| | | | | Not detected |
EOMES | Eomesodermin | Disease related genes Transcription factors
| | | | | Tissue enhanced |
EPAS1 | Endothelial PAS domain protein 1 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
ERG | V-ets avian erythroblastosis virus E26 oncogene homolog | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ESR2 | Estrogen receptor 2 (ER beta) | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ESRRA | Estrogen-related receptor alpha | Nuclear receptors Transcription factors
| | | | | Expressed in all |
ESRRG | Estrogen-related receptor gamma | FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ESX1 | ESX homeobox 1 | Transcription factors
| | | | | Tissue enriched |
ETS1 | V-ets avian erythroblastosis virus E26 oncogene homolog 1 | Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |